NSJ Bioreagents

Leukocyte Marker Antibody Overview

Leukocyte Marker Antibody detects proteins expressed in leukocytes, the white blood cells that form the backbone of the immune system. Leukocytes encompass a diverse set of cells, including lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Together, they orchestrate innate and adaptive immune responses, providing protection against pathogens while regulating tissue homeostasis.

Markers commonly recognized by Leukocyte Marker Antibodies include CD45 (a pan-leukocyte marker), CD3 (T cells), CD19/CD20 (B cells), CD14 (monocytes), CD15 (granulocytes), and CD11b/CD18 (myeloid cells). CD45 is the gold standard for identifying all leukocytes, while lineage-specific markers refine identification of subsets. The Leukocyte Marker Antibody is therefore indispensable for immunologists, hematologists, and pathologists aiming to study immune cell populations in both healthy and diseased states.

Because leukocytes are involved in infection, autoimmunity, allergy, and cancer, Leukocyte Marker Antibodies are widely used across research, diagnostics, and translational applications.

Why Choose Leukocyte Marker Antibodies from NSJ Bioreagents?

NSJ Bioreagents provides Leukocyte Marker Antibodies validated for immunohistochemistry, flow cytometry, western blotting, immunofluorescence, and ELISA. Each Leukocyte Marker Antibody undergoes rigorous specificity testing to confirm accurate detection of leukocyte proteins, minimizing cross-reactivity with non-hematopoietic cells.

By selecting a Leukocyte Marker Antibody from NSJ Bioreagents, scientists gain reagents optimized for reproducibility and clarity. Our antibodies deliver robust staining in tissue sections, sharp population profiles in flow cytometry, and consistent performance across biochemical assays. With detailed datasheets, recommended positive controls, and optimized protocols, NSJ Bioreagents ensures that Leukocyte Marker Antibodies support reliable, interpretable results for both discovery and clinical studies.

Applications of Leukocyte Marker Antibodies

The Leukocyte Marker Antibody has wide-ranging applications across immunology, hematology, oncology, and translational science.

1) Immunology and Host Defense

Leukocyte Marker Antibodies identify immune cell subsets during infection.
The Leukocyte Marker Antibody helps analyze trafficking of leukocytes to inflamed tissues.
Researchers use Leukocyte Marker Antibodies to study cytokine-producing leukocytes.

2) Autoimmunity and Inflammation

Leukocyte Marker Antibodies are applied to investigate immune infiltration in rheumatoid arthritis, lupus, and multiple sclerosis.
The Leukocyte Marker Antibody distinguishes pathogenic leukocyte subsets driving chronic inflammation.
Researchers use Leukocyte Marker Antibodies to evaluate immunomodulatory therapies.

3) Oncology and Tumor Immunology

Tumor-infiltrating leukocytes are detected with Leukocyte Marker Antibodies.
The Leukocyte Marker Antibody helps evaluate immune microenvironments predictive of therapy response.
Leukocyte Marker Antibodies are applied in biomarker discovery for immuno-oncology.

4) Hematology and Blood Disorders

Leukocyte Marker Antibodies are used to classify leukemias and lymphomas.
The Leukocyte Marker Antibody supports bone marrow analysis in hematologic malignancies.
Researchers employ Leukocyte Marker Antibodies in flow cytometry panels for immune phenotyping.

5) Infectious Disease

Leukocyte Marker Antibodies track immune responses to viral, bacterial, and parasitic pathogens.
The Leukocyte Marker Antibody is used to measure leukocyte depletion or hyperactivation in sepsis and HIV.
Researchers apply Leukocyte Marker Antibodies to vaccine studies for immune monitoring.

6) Transplantation and Tolerance

Leukocyte Marker Antibodies evaluate immune compatibility in organ and bone marrow transplantation.
The Leukocyte Marker Antibody supports monitoring of immune reconstitution post-transplant.
Researchers use Leukocyte Marker Antibodies to investigate graft-versus-host disease.

7) Translational and Clinical Research

Leukocyte Marker Antibodies validate biomarkers predictive of disease progression.
The Leukocyte Marker Antibody is used in clinical trials to monitor therapeutic effects on leukocytes.
Leukocyte Marker Antibodies support drug discovery targeting immune regulation.

Why Are Leukocyte Marker Antibodies Important?

Leukocytes are central to immune defense and pathology. The Leukocyte Marker Antibody provides a reliable means to detect these critical cells, while Leukocyte Marker Antibodies more broadly empower discoveries across immunology, oncology, hematology, and translational research.

In basic science, Leukocyte Marker Antibodies illuminate immune diversity and function. In pathology, the Leukocyte Marker Antibody supports diagnosis of leukemias, lymphomas, and immune deficiencies. In clinical translation, Leukocyte Marker Antibodies validate biomarkers and therapeutic interventions.

Clinically, leukocyte markers are routinely used in diagnostics and prognostics. The Leukocyte Marker Antibody ensures precise measurement, bridging molecular research with patient outcomes and enabling precision medicine.

Conclusion

Leukocytes form the backbone of the immune system, defending against pathogens while shaping adaptive responses. The Leukocyte Marker Antibody equips researchers and clinicians with a dependable tool for identifying and analyzing leukocytes, while Leukocyte Marker Antibodies more broadly support research in immunology, oncology, autoimmunity, and translational medicine. By connecting immune biology with clinical care, these antibodies remain indispensable for advancing both discovery and therapeutic development.